Shilpa Madari

Shilpa Madari has extensive experience in the pharmaceutical industry, particularly in pharmacology and drug metabolism. At Boehringer Ingelheim since July 2017, Shilpa has progressed through roles including Trial Clinical Pharmacologist and Scientist IV, focusing on non-clinical DMPK and conducting various in vitro cell-based assays. Prior to this, Shilpa worked at Bristol-Myers Squibb from August 2010, taking on positions such as Research Scientist. Shilpa holds an education from the University of New Haven, completed between 2008 and 2010, and attended St. Ann's High School.